4.7 Review

Mitochondrial Ca2+ Signaling and Bioenergetics in Alzheimer's Disease

Journal

BIOMEDICINES
Volume 10, Issue 12, Pages -

Publisher

MDPI
DOI: 10.3390/biomedicines10123025

Keywords

calcium; Alzheimer's disease; mitochondria; bioenergetics; neuron; microglia; astrocyte; AD mouse model; iPSCs

Funding

  1. University of Padova
  2. Italian Ministry of University and Scientific Research
  3. Cure Alzheimer's Fund [PRIN2017XA5J5N]
  4. UNIPD Funds for Research Equipment
  5. CARIPARO excellence project
  6. European Commission [2018/113]

Ask authors/readers for more resources

Alzheimer's disease is a neurodegenerative illness characterized by the loss of neurons in specific brain areas. The calcium hypothesis is at the forefront of current research as a potential key pathway in Alzheimer's disease.
Alzheimer's disease (AD) is a hereditary and sporadic neurodegenerative illness defined by the gradual and cumulative loss of neurons in specific brain areas. The processes that cause AD are still under investigation and there are no available therapies to halt it. Current progress puts at the forefront the calcium (Ca2+) hypothesis as a key AD pathogenic pathway, impacting neuronal, astrocyte and microglial function. In this review, we focused on mitochondrial Ca2+ alterations in AD, their causes and bioenergetic consequences in neuronal and glial cells, summarizing the possible mechanisms linking detrimental mitochondrial Ca2+ signals to neuronal death in different experimental AD models.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available